Engineering Antibody Evolution: Germline-Targeting HIV Vaccines Reach a Turning Point

Rowena A Bull1,2, Deborah L Burnett1,3

  • 1School of Biomedical Sciences, UNSW Sydney, Kensington, New South Wales, Australia.